RegentAtlantic Capital’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.22M Sell
40,288
-90
-0.2% -$3.3K 0.04% 269
2022
Q2
$1.41M Buy
40,378
+49
+0.1% +$1.93K 0.05% 252
2022
Q1
$2.1M Buy
+40,329
New +$2.03M 0.06% 215

Other funds holding DOCS

RegentAtlantic Capital's DOCS Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Doximity (DOCS) stake by 0.22% in Q3 2022, selling an estimated $3.3K and leaving 40,288 shares worth $1.22M. The position accounts for 0.04% of the portfolio, ranked #269.

RegentAtlantic Capital first reported a position in DOCS in Q1 2022 and has held it in 3 quarters since. The position peaked at $2.1M in Q1 2022. 271 funds tracked by Wall St. Rank hold DOCS as of Q3 2022.

  • RegentAtlantic Capital held 40,288 shares of Doximity worth $1.22M as of Q3 2022.
  • RegentAtlantic Capital sold 90 Doximity shares in Q3 2022, an estimated $3.3K.
  • Doximity made up 0.04% of RegentAtlantic Capital's portfolio in Q3 2022, its #269 holding.
  • RegentAtlantic Capital first reported a position in Doximity in Q1 2022 and has held it in 3 quarters since.
  • RegentAtlantic Capital's Doximity position peaked at $2.1M in Q1 2022.
  • 271 funds tracked by Wall St. Rank held Doximity as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.